According to a recent analysis, Windtree Therapeutics Inc (NASDAQ: WINT) expects to reach a high of $8 soon. The stock improved by 36.36% and closed at $2.70 on June 4, 2021. Windtree targets treatments for respiratory diseases using innovative KL4 surfactant therapies, which are in the development stage. Its technology […]
